Abstract Details
| Michael Johnson, PhD
					(Eli Lilly & Company) PRESENTER | No disclosure on file | 
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Kirk W. Johnson, PhD (Eli Lilly and Company) | No disclosure on file |